Measures IgG, IgM and IgA antibodies directed against beta-2 glycoprotein 1, a protein involved in antiphospholipid antibody activity.
Used to support the evaluation of suspected antiphospholipid syndrome (APS), particularly in people with unexplained thrombosis, pregnancy-related complications, or systemic autoimmune disease.